PEOPLE ON THE MOVE
Frontage
Frontage, a full-service CRO with facilities in the US and China, has taken on Michael Willett as president of its clinical business.
Willett has more than two decades of experience in clinical research, starting when he established Advanced Biomedical Research, Inc., an early-phase CRO later acquired by Frontage. He left Frontage in 2009 to start Ready Clinical LLC, a regulatory and clinical consultancy.
“I am very excited to work with Michael once again as he leads our clinical operations,” said Frontage CEO Song Li.
Willett added,“Song has built a phenomenal, versatile organization and the new state-of-the-art 160-bed Phase I-II unit in Secaucus will allow us to better serve our valued clients. I look forward to leading the clinical operations team to even greater success.”
